» Articles » PMID: 33490072

Blockade of Macrophage CD147 Protects Against Foam Cell Formation in Atherosclerosis

Overview
Specialty Cell Biology
Date 2021 Jan 25
PMID 33490072
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The persistence of macrophage-derived foam cells in the artery wall fuels atherosclerosis development. However, the mechanism of foam cell formation regulation remains elusive. We are committed to determining the role that CD147 might play in macrophage foam cell formation during atherosclerosis. In this study, we found that CD147 expression was primarily increased in mouse and human atherosclerotic lesions that were rich in macrophages and could be upregulated by ox-LDL. High-throughput compound screening indicated that ox-LDL-induced CD147 upregulation in macrophages was achieved through PI3K/Akt/mTOR signaling. Genetic deletion of macrophage protected against foam cell formation by impeding cholesterol uptake, probably through the scavenger receptor CD36. The opposite effect was observed in primary macrophages isolated from macrophage-specific -overexpressing mice. Moreover, bioinformatics results indicated that CD147 suppression might exert an atheroprotective effect via various processes, such as cholesterol biosynthetic and metabolic processes, LDL and plasma lipoprotein clearance, and decreased platelet aggregation and collagen degradation. Our findings identify CD147 as a potential target for prevention and treatment of atherosclerosis in the future.

Citing Articles

Inflammation in atherosclerosis: pathophysiology and mechanisms.

Ajoolabady A, Pratico D, Lin L, Mantzoros C, Bahijri S, Tuomilehto J Cell Death Dis. 2024; 15(11):817.

PMID: 39528464 PMC: 11555284. DOI: 10.1038/s41419-024-07166-8.


Bacillus amyloliquefaciens Protect Against Atherosclerosis Through Alleviating Foam Cell Formation and Macrophage Polarization.

Xue Q, Ma Y, Shao H Curr Microbiol. 2024; 81(9):263.

PMID: 38997545 DOI: 10.1007/s00284-024-03775-w.


Cyclophilin A/CD147 Interaction: A Promising Target for Anticancer Therapy.

Han J, Jung H Int J Mol Sci. 2022; 23(16).

PMID: 36012604 PMC: 9408992. DOI: 10.3390/ijms23169341.

References
1.
Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K . Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol. 2000; 20(8):1953-60. DOI: 10.1161/01.atv.20.8.1953. View

2.
Grebe A, Hoss F, Latz E . NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circ Res. 2018; 122(12):1722-1740. DOI: 10.1161/CIRCRESAHA.118.311362. View

3.
Wang S, Chao D, Wei W, Nan G, Li J, Liu F . CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020; 39(1):145. PMC: 7391525. DOI: 10.1186/s13046-020-01647-2. View

4.
Xu Z, Liu R, Huang L, Xu Y, Su M, Chen J . CD147 Aggravated Inflammatory Bowel Disease by Triggering NF-B-Mediated Pyroptosis. Biomed Res Int. 2020; 2020:5341247. PMC: 7352133. DOI: 10.1155/2020/5341247. View

5.
Li J, Huang Q, Long X, Zhang J, Huang X, Aa J . CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways. J Hepatol. 2015; 63(6):1378-89. DOI: 10.1016/j.jhep.2015.07.039. View